Vistara Single-gene NIPT

Prenatal noninvasive test for single-gene screening

Vistara> tests 25 serious genetic diseases, with a single blood sample taken from the mother. The results will be sent to the doctor in 2-3 weeks.

Provide clinically actionable information:
- Many single-gene conditions benefit from early intervention
- Inform decisions for pregnancy and delivery management, early interventions, and patient education to ensure every child reaches their full potential

Perform testing with ease and get clear results
- No paternal and/or egg-donor* sample necessary
- Find conditions other screening modalities would miss until after the window for critical intervention

*if applicable

Vistarascreens conditions with a combined incidence greater than Down syndrome^1,2

Some scenarios where single-gene NIPT should be considered

Couples with a male partner over 40-years-old

Ultrasound anomalies including shortened long bones and increased nuchal translucency

Family history of hereditary conditions

Patients who want as much information as possible

Vistara’s clinical validation published in Nature Medicine (Zhang et al) showed the following performance metrics:²

Make confident pregnancy management and early intervention decisions with performance you can trust.

Vistara single-gene NIPT:

References

₁Snijders, et al. Ultrasound Obstet Gynecol 1999;13:167-170.

₂Zhang J et al. Nat Med. 2019 Mar;25(3):439-447.

₃Pagon RA et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.